Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study

INTRODUCTION: Older age and longer disease duration are key risk factors for hypoglycemia in patients with type 2 diabetes (T2D) who receive insulin. Previous studies have shown that insulin glargine 300 U/mL (Gla-300) improves glycemic control and reduces the risk of hypoglycemia, but whether this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolnik, B., Hryniewiecki, A., Pisarczyk-Wiza, D., Szczepanik, T., Klupa, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873339/
https://www.ncbi.nlm.nih.gov/pubmed/35034328
http://dx.doi.org/10.1007/s13300-021-01199-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873339/
https://www.ncbi.nlm.nih.gov/pubmed/35034328
http://dx.doi.org/10.1007/s13300-021-01199-4

Ejemplares similares